Company profile
Biotechnology · Thousand Oaks, California · amgen.com
Amgen Inc. is a leading biotechnology company specializing in human therapeutics, with a focus on innovative medicines for serious illnesses. The company continues to advance its research and development efforts to address unmet medical needs.
To accelerate treatment development for patients with complex cancers.
Launched Amgen Partners of Choice network with eight leading oncology academic centers.
AMGEN LAUNCHES PARTNERS OF CHOICE NETWORK OF EIGHT LEADING ONCOLOGY ACADEMIC CENTERS
To leverage machine learning and AI in drug discovery.
Collaborated with Generate Biomedicines to develop novel protein therapeutics using AI.
To create therapies targeting disease-driving proteins.
Invested in DNA-encoded libraries and external partnerships for induced proximity medicines.
Induced Proximity: Turning Molecular Matchmakers into Medicines
To reach more patients worldwide.
Established a presence in approximately 100 countries, delivering medicines to millions.
Amgen is leveraging advanced technologies, including AI and machine learning, to enhance its drug discovery and development processes.
Amgen's AI initiatives are central to its research and development strategy.
This is a neutral public preview. Sign in to generate your own personalized brief, with stakeholder angles, talk tracks and where your solution fits, tailored to how you sell.
Generate a full briefYour first brief is free, no card required.
Evidence confidence 90/100. Generated 2026-07-08 from public sources.